Having demonstrated the anti-metastatic role of galectin-8 in vitro and in vivo, we next evaluated whether treatment of CRC cells with recombinant galectin-8 (rGal-8) mimicked the effect of endogenous galectin-8 on CRC cells. Here, LGALS8 is linked to colorectal carcinoma.